Chemotherapy right after surgery for high-risk bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether giving chemotherapy immediately after surgery can help people with high-risk, non-muscle-invasive bladder cancer. It aims to reduce the chance of the cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high-risk bladder cancer that has not reached the muscle layer.
- Your cancer includes features like high-grade tumors, tumor larger than 3 cm, multiple tumors, carcinoma in situ, or other concerning features.
- You are in generally good health and can be followed for 2 years.
- You have not had previous chemotherapy, immunotherapy, or radiation for bladder cancer.
- You do not have other serious medical conditions like active infections or low blood cell counts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy and immunotherapy to treat large, non-invasive bladder cancer before and after surgery. It aims to avoid removing the bladder while still effectively treating the cancer.
This trial tests whether giving chemotherapy before surgery can improve outcomes for people with high-risk cancer in the upper urinary tract (the tubes that carry urine from the kidneys to the bladder). The chemotherapy is given before the standard surgery to remove the affected kidney and ureter.
This trial tests a combination of two treatments after bladder tumor surgery: a drug called toripalimab (given through a vein) plus BCG therapy (given into the bladder) for people with high-risk non-muscle-invasive bladder cancer. The goal is to see if this combination can help prevent the cancer from coming back.
This trial tests whether giving mitomycin directly into the bladder before surgery can help people with high-risk non-muscle-invasive bladder cancer. The goal is to see if this approach is safe and effective at preventing cancer from coming back.
This trial tests giving chemotherapy before surgery to remove the bladder, to see if it can improve outcomes for patients with muscle-invasive bladder cancer. The treatment is personalized based on a lab test of your tumor cells, which may help make the therapy more effective.
This study looks at a treatment plan that uses a combination of chemotherapy and radiation to try to cure bladder cancer without removing the bladder. It is for people who have had bladder cancer come back several times or who did not get good results from BCG treatment.
Hear when a new NMIBC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.